scispace - formally typeset
Journal ArticleDOI

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis

Reads0
Chats0
TLDR
The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including “monosymptomatic” disease suggestive of MS, disease with a typical relapsing‐remitting course, and disease with insidious progression, without clear attacks and remissions.
Citations
More filters
Journal ArticleDOI

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

TL;DR: Reduced inflammatory activity (CXCL13, CHI3L1, and CHIT1) and reduced axonal damage (NFL) in patients switching from first-line DMTs to fingolimod indicate similar effects on inflammatory and degenerative processes.
Journal ArticleDOI

Immunmodulatorische Stufentherapie der multiplen Sklerose

TL;DR: Natalizumab is only approved for monotherapy after basic treatment has failed or for rapidly progressive relapsing-remitting MS, as new developments in the diagnostic work-up and immunotherapy of multiple sclerosis as well as optimization of medical care for MS patients are reflected.
Journal ArticleDOI

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,

TL;DR: Omega-3 FA significantly decreased MMP-9 levels in RRMS and may act as an immune-modulator that has potential therapeutic benefit in MS patients and is coupled with a significant increase in omega-3FA levels in red blood cell membranes.
Journal ArticleDOI

Revised definition of neuropathic pain and its grading system: an open case series illustrating its use in clinical practice.

TL;DR: This open case series of 5 outpatients demonstrates how the grading system can be applied, in combination with appropriate confirmatory testing, to diagnosis neuropathic conditions in clinical practice.
Journal ArticleDOI

Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients.

TL;DR: Modafinil was tolerated in 75% of patients at small doses and seemed to improve the severity of fatigue in the MS and BDS groups but not in the CS group, and there was no modification in measured physical activity.
References
More filters
Journal ArticleDOI

The clinical course of neuromyelitis optica (Devic's syndrome)

TL;DR: Clinical, laboratory, and imaging features generally distinguish neuromyelitis optica from MS, and patients with relapsing optic neuritis and myelitis may have neuromyeliitis opticas rather than MS.
Journal ArticleDOI

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

TL;DR: It is concluded that a four-parameter dichotomized MRI model including gadolinium-enhancement, juxtacortical, infratentorial and periventricular lesions best predicts conversion to clinically definite multiple sclerosis.
Journal ArticleDOI

MRI in the diagnosis of MS A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

TL;DR: MRI was the best method for demonstrating dissemination in space and laboratory-supported definite MS (LSDMS) could be diagnosed in 85 patients of the total 200, and MRI predicted that diagnosis in 18/19 (95%).
Related Papers (5)